Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pacira Pharmaceuticals Inc (NASDAQ:PCRX)

38.85
Delayed Data
As of 4:00pm ET
 -1.14 / -2.85%
Today’s Change
35.78
Today|||52-Week Range
80.25
-49.41%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues59.1M62.2M69.3M65.5M
 
 
 
 
 
Cost of Goods Sold16.1M13.0M16.3M17.1M
 
 
 
 
 
Depreciation And Amortization2.8M2.9M3.1M3.2M
 
 
 
 
 
 
Operating ExpensesGross Income40.2M46.3M49.9M45.2M
 
 
 
 
 
General Expenses38.4M41.2M50.7M47.5M
 
 
 
 
 
Research And Development3.6M5.9M13.2M9.5M
 
 
 
 
 
Total Operating Expenses57.3M57.1M70.1M67.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income1.8M5.1M-813.0K-2.3M
 
 
 
 
 
Extraordinary Charge-51.0K0.00-1.0K0.00
 
 
 
Interest Expense On Debt2.1M2.1M2.1M2.1M
 
 
 
 
 
Other Expenses43.0K-8.0K-83.0K48.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income47.0K3.4M-2.6M-3.8M
 
 
 
 
 
Income Taxes-39.0K-281.0K-108.0K-32.0K
 
 
 
 
 
Net Income8.0K3.1M-2.5M-3.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS36.5M36.7M36.8M37.0M
 
 
 
 
 
Shares To Calculate EPS Diluted41.4M41.0M36.8M37.0M
 
 
 
 
 
 
Earnings Per ShareEPS$0.00$0.08-$0.07-$0.10
 
 
 
 
EPS Diluted$0.00$0.08-$0.07-$0.10